1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,424 | 0,430 | 09:26 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.09. | Dividendenbekanntmachungen (18.09.2026) | 7.123 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ADR US00400T1025 1,0607 USD 0,9241 EUR BANK7 CORP US06652N1072 0,3 USD 0,2613 EUR CHU KONG SHIPPING ENTERPRISES... ► Artikel lesen | |
| 07.09. | ORBUSNEICH (06929): INTERIM REPORT 2026 | 1 | HKEx | ||
| 17.08. | ORBUSNEICH (06929): CHANGE OF OFFICERS AND COMPANY SECRETARY | 1 | HKEx | ||
| 14.08. | ORBUSNEICH (06929): DECLARATION OF INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS (UPDATED) | 1 | HKEx | ||
| ORBUSNEICH MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
| 13.08. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Reports Growth Across All Geographies in 2026 Interim Results | 2.743 | JCN Newswire | - Revenue Up 18.1% to US$98.7 Million- Net Profit Rises to US$21.6 Million- Declares First Interim Dividend of HK8 Cents Per ShareHONG KONG, Aug 13, 2026 - (ACN Newswire) - Results Highlights:- Revenue... ► Artikel lesen | |
| 13.08. | OrbusNeich Medical Group Holdings Limited H1 Profit Climbs | 5 | RTTNews | ||
| 13.08. | ORBUSNEICH (06929): DECLARATION OF INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS | 6 | HKEx | ||
| 13.08. | ORBUSNEICH (06929): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 2 | HKEx | ||
| 31.07. | ORBUSNEICH (06929): DATE OF BOARD MEETING | 1 | HKEx | ||
| 24.07. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Announces Enrollment of First Patient in Japan Clinical Trial for its Proprietary Drug-Coated Balloon | 787 | JCN Newswire | HONG KONG, July 22, 2026 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group' stock code: 6929), a multinational medical device company specializing in interventional... ► Artikel lesen | |
| 22.07. | ORBUSNEICH (06929): VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLMENT IN JAPAN CLINICAL TRIAL FOR ITS PROPRIETARY DRUG-COATED BALLOON | 1 | HKEx | ||
| 09.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.06.2026 | 961 | Xetra Newsboard | Das Instrument G85 CA35958L1013 FUERTE METALS CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 09.06.2026 und ex Kapitalmassnahme am 10.06.2026 The instrument G85 CA35958L1013 FUERTE METALS CORP.... ► Artikel lesen | |
| 08.06. | ORBUSNEICH (06929): (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 8, 2026 AND (2) PAYMENT OF FINAL DIVIDEND | 1 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): REMINDER LETTER TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT AND CIRCULAR INCLUDING NOTICE OF ANNUAL ... | 1 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): REMINDER LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR INCLUDING NOTICE OF ANNUAL GENERAL ... | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 8, 2026 | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, (3) ... | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | 2 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): ANNUAL REPORT 2025 | 2 | HKEx |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 63,75 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| HEARTFLOW | 50,70 | +0,02 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,375 | +0,06 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| BILLIONTOONE | 99,97 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| GENEDX | 71,50 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| ANTERIS TECHNOLOGIES GLOBAL | 7,050 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Statement of CDIs on issue - AVR | ||
| QTREX QUANTUM | 1,580 | -0,63 % | Qtrex Quantum jumps 40% | ||
| PROGYNY | 25,920 | +0,04 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,125 | +0,04 % | KeyBanc raises Lifestance Health stock price target on specialty care growth | ||
| PRIVIA HEALTH GROUP | 20,260 | -0,10 % | Full Transcript: Privia Health Gr Q2 2026 Earnings Call | ||
| BETA BIONICS | 18,660 | +0,16 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| PACS GROUP | 42,820 | +0,04 % | Omega Healthcare transitions 32 Florida facilities to PACS Group | ||
| 908 DEVICES | 12,330 | 0,00 % | Canaccord initiates 908 Devices stock coverage with buy rating | ||
| PROCEPT BIOROBOTICS | 17,525 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report |
Das Unternehmen ORBUSNEICH MEDICAL GROUP HOLDINGS LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,54 % bei einem Aktienkurs von 0,366 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ORBUSNEICH MEDICAL GROUP HOLDINGS LTD finden Sie auf Wallstreet Online.